Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina TbkISX:HEAL 67 PS Ratio is 1.66 as of Aug. 05, 2026, which is 46% below its 10-year median of 3.09. GuruFocus rates ISX:HEAL with a GF Score™ of 67/100 and a GF Value™ of Rp1,554.15 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 657 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks worse than 52.21% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PT Medikaloka Hermina Tbk's share price is Rp795.00.
PT Medikaloka Hermina Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was Rp479.43. Hence, PT Medikaloka Hermina Tbk's PS Ratio for today is 1.66.
Good Sign:
PT Medikaloka Hermina Tbk stock PS Ratio (=1.67) is close to 10-year low of 1.67.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's PS Ratio or its related term are showing as below:
ISX:HEAL'
s PS Ratio Range Over the Past 10 Years
Min: 1.66 Med: 3.09 Max: 5.06
Current: 1.66
During the past 11 years, PT Medikaloka Hermina Tbk's highest PS Ratio was 5.06. The lowest was 1.66. And the median was 3.09.
ISX:HEAL's PS Ratio is ranked worse than 52.21% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs ISX:HEAL: 1.66
During the past 12 months, the average Revenue per Share Growth Rate of PT Medikaloka Hermina Tbk was 7.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 12.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 14.40% per year.
During the past 11 years, PT Medikaloka Hermina Tbk's highest 3-Year average Revenue per Share Growth Rate was 22.40% per year. The lowest was 4.80% per year. And the median was 14.00% per year.
PT Medikaloka Hermina Tbk (ISX:HEAL) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PT Medikaloka Hermina Tbk PS Ratio Related Terms
PT Medikaloka Hermina Tbk PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's PS Ratio distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PT Medikaloka Hermina Tbk's Share Price of today is Rp795.00. PT Medikaloka Hermina Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp479.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PT Medikaloka Hermina Tbk (ISX:HEAL) has a PS Ratio of 1.66 as of Aug. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 46% below median its historical median of 3.09. Over the past decade, PT Medikaloka Hermina Tbk's PS Ratio has ranged from 1.66 to 5.06. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #343 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 52.2%.
Is PT Medikaloka Hermina Tbk's PS Ratio too high?
PT Medikaloka Hermina Tbk's current PS Ratio of 1.66 is 46% below median its 10-year median of 3.09. Over the past 10 years, this metric has ranged from a low of 1.66 to a high of 5.06. The Healthcare Providers & Services industry median PS Ratio is 1.51. PT Medikaloka Hermina Tbk's value of 1.66 is 9.9% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #343 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #343 out of 657 companies for PS Ratio. This places PT Medikaloka Hermina Tbk in the lower half of its industry. The industry median PS Ratio is 1.51. PT Medikaloka Hermina Tbk's value of 1.66 is 9.9% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own PS Ratio has ranged from 1.66 to 5.06 over the past decade. While the company's 10-year median is 3.09 vs. the industry median of 1.51, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current PS Ratio of 1.66 is 9.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current PS Ratio is 1.66, which is 46% below median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,554.15, compared to a current price of Rp795.00 — trading 48.8% below its estimated fair value. The current PS Ratio is 1.66, which is 46% below median its 10-year median of 3.09 and 9.9% above the Healthcare Providers & Services industry median of 1.51. PT Medikaloka Hermina Tbk's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current PS Ratio is 1.66 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp795.00 is trading 48.8% below its estimated GF Value™ of Rp1,554.15.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
PS Ratio: 1.66 (46% below median its 10-year median of 3.09)
GF Value™: Rp1,554.15 vs. price of Rp795.00 (48.8% below fair value)
Industry Position: 9.9% above the Healthcare Providers & Services median (#343 of 657)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
67GF Score
Get the complete analysis for ISX:HEAL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
